Clinical electrical muscle stimulation has been shown to alleviate muscle atrophy resulting from functional disuse, yet little is known about its effect on the skeleton. The objective of this study is to evaluate the potential of dynamic muscle stimulation on disused trabecular bone, and to investigate the importance of optimized stimulation frequency in the loading regimen. Fifty-six skeletally mature Sprague-Dawley rats were divided into seven groups for the 4-week experiment: baseline control, age-matched control, hindlimb suspended (HLS), and HLS with muscle stimulation at 1 Hz, 20 Hz, 50 Hz, and 100 Hz. Muscle stimulation was carried out for 10 minutes per day for 5 days per week, total of 4 weeks. The metaphyseal and epiphyseal trabecular regions of the distal femurs were analyzed with microcomputed tomography and histomorphometry methods. HLS alone for 4-week resulted in a significant amount of trabecular bone loss and structural deterioration. Muscle contraction at 1 Hz was not sufficient to inhibit trabecular bone loss and resulted in similar amount of loss to that of HLS alone. Bone quantity and structure were significantly improved by applying muscle stimulation at mid-frequency (20 Hz & 50 Hz). Dynamic stimulation at 50 Hz demonstrated the greatest preventive effect on the skeleton against functional disused alone animals (up to +147% in bone volume fraction, +38% in trabecular number and -36% in trabecular separation). Histomorphometric analysis showed that the stimulation, regardless of its frequency, did not have an effect on the bone formation indices, such as mineral apposition rate and bone formation rate. Overall, the data demonstrated the potentials of frequency-dependent dynamic muscle contraction in regulating skeletal adaptive responses under disuse conditions. Dynamic muscle stimulation, with a specific regimen, may be beneficial to future orthopedic research in developing a countermeasure for disuse osteopenia and osteoporosis.

Intramedullary pressure (ImP) and low-level bone strain induced by oscillatory muscle stimulation (MS) has the potential to mitigate bone loss induced by disuse osteopenia, i.e., hindlimb suspension (HLS). To test this hypothesis, we evaluated a) MS induced ImP and bone strain as function of stimulation frequency, and b) the adaptive responses to functional disuse, and disuse plus 1Hz and 20Hz stimulation in vivo. Femoral ImP and bone strain generated by MS were measured in the frequencies of 1Hz-100Hz in four rats. Forty retired breeder rats were used for the in vivo HLS study. The quadriceps muscle was stimulated at frequencies of 1 Hz and 20 Hz, 10min/d for 4 weeks. The metaphyseal trabecular bone quantity and microstructure at the distal femur were evaluated using μCT, while bone formation indices were analyzed using histomorphometric techniques. Oscillatory MS generated a maximum ImP of 45±9 mmHg at 20 Hz and produced a maximum matrix strain of 128±19 με at 10 Hz. Our analyses from the in vivo study showed that MS at 20 Hz was able to attenuate trabecular bone loss and partially maintain the microstructure induced by HLS. Conversely, there was no evidence of an adaptive effect of stimulation at 1 Hz on disused skeleton. The results suggested that oscillatory MS regulates fluid dynamics and mechanical strain in bone, which serves as a critical mediator of adaptation. These results clearly demonstrated the ability of MS in attenuating bone loss from the disuse osteopenia and could hold potential in mitigating skeletal degradation imposed by conditions of disuse, which may serve as a biomechanical intervention in clinic application.

Proper spatial localization of EGFR signaling activated by autocrine ligands represents a critical factor in embryonic development as well as tissue organization and function, and ligand/receptor binding affinity is among the molecular and cellular properties suggested to play a role in governing this localization. We employ a computational model to predict how receptor-binding affinity affects local capture of autocrine ligand vis-a-vis escape to distal regions, and provide experimental test by constructing cell lines expressing EGFR along with either wild-type EGF or a low-affinity mutant, EGF(L47M). The model predicts local capture of a lower affinity autocrine ligand to be less efficient when the ligand production rate is small relative to receptor appearance rate. Our experimental data confirm this prediction, demonstrating that cells can use ligand/receptor binding affinity to regulate ligand spatial distribution when autocrine ligand production is limiting for receptor signaling.